Written by the Nuvirox Research Team
Key Points
- A 2024 systematic review and meta-analysis of 8 double-blind RCTs (498 patients) found topical capsaicin meaningfully reduced OA pain severity compared to placebo.
- A separate network meta-analysis found capsaicin performs roughly on par with topical NSAIDs at licensed doses, though no trial has directly compared the two head-to-head.
- The burning, stinging sensation on application is common, expected, and the main reason people stop using it — not a sign something is wrong.
Short answer: yes, topical capsaicin has real trial support for reducing osteoarthritis pain, roughly in the same range as topical NSAIDs — but expect a burning sensation, especially in the first days of use. Capsaicin is the compound that makes chili peppers hot, and applied to the skin repeatedly it depletes substance P, a neurotransmitter involved in transmitting pain signals from peripheral nerves.
How strong is the trial evidence?
A 2024 systematic review and meta-analysis pooled eight double-blind randomized controlled trials covering 498 osteoarthritis patients. Compared with placebo, topical capsaicin (concentrations ranging 0.0125%–5%) meaningfully reduced pain severity on a visual analog scale, with a standardized mean difference of -0.84 — a moderate-to-large effect by conventional statistical benchmarks. Five of the eight trials were rated low risk of bias, three at higher risk, which is a reasonably good quality mix for this kind of topical-therapy literature.
How does it compare to topical NSAIDs like diclofenac gel?
A separate, large network meta-analysis (28 RCTs, over 7,300 participants) directly modeled topical NSAIDs against topical capsaicin for OA pain relief. Topical NSAIDs were statistically superior to placebo both overall and at licensed doses. Capsaicin was only statistically superior to placebo when used at its licensed dose — and critically, no trial in the network directly compared topical NSAIDs against capsaicin head-to-head, so the "capsaicin vs. NSAID" comparison is an indirect, modeled estimate. That modeled comparison found no significant difference in pain relief between the two classes at licensed doses, suggesting they're roughly comparable options for someone with pain concentrated in one or a few joints.
Why does it burn, and does that mean it's working?
The burning and stinging sensation on application is a direct, expected consequence of capsaicin activating the same heat/pain receptor (TRPV1) it's ultimately trying to desensitize with repeated use. It typically lessens over the first several days to two weeks of consistent application as the nerve endings' substance P stores deplete. It's not a sign of tissue damage, but it is the single biggest reason people stop using capsaicin cream before giving it a fair trial — trial dropout and adherence issues related to this burning sensation show up repeatedly in the underlying research.
Illustrative pattern reported across trials: burning sensation tends to be highest early and fade with consistent use, while pain relief builds gradually over the same window. Not plotted from a single dataset.
What capsaicin cream won't do
It hasn't been shown to change the underlying disease process in osteoarthritis — it's a symptom-relief tool, not a disease-modifying one. It's also not well suited to widespread pain across many joints, since applying it broadly increases the burning-sensation burden without much practical advantage over an oral option. Avoid applying it near broken skin, eyes, or mucous membranes, and always wash hands thoroughly after application (or use gloves) since even trace amounts transferred to eyes or sensitive skin can cause significant irritation. If your joint pain includes swelling, redness, warmth, or systemic symptoms, see a doctor rather than relying on a topical alone.
Dosing and realistic timelines
Licensed capsaicin OA products are typically in the 0.025%–0.075% range, applied 3–4 times daily to the affected joint; higher-concentration patches (up to 8%) exist for other indications under medical supervision. Give it at least two to four weeks of consistent use before judging effectiveness, since both the burning-sensation reduction and the pain-relief effect build gradually over that window, per the trials reviewed.
Who is a topical like capsaicin actually best suited for?
Topical treatments in general make the most sense when pain is concentrated in one or a couple of accessible joints — a single knee, the base of a thumb, an ankle — rather than spread diffusely across many joints, since applying cream to a large body surface repeatedly multiple times a day becomes impractical and increases the total burning-sensation burden without a clear efficacy advantage. This is a useful complementary approach alongside oral options: someone dealing with localized knee pain from osteoarthritis might reasonably use a topical capsaicin or NSAID directly on that joint while also considering an oral supplement like the ones discussed in our turmeric and curcumin review for broader systemic support. It's worth distinguishing joint-line osteoarthritis pain, which is what these capsaicin trials specifically studied, from pain originating in surrounding soft tissue like bursae or tendons, covered in our bursitis vs. tendinitis vs. arthritis article — the source of the pain affects how well a topical applied directly over the joint is likely to help.
People who specifically dislike or can't tolerate oral NSAIDs due to stomach issues, kidney concerns, or interactions with other medications are also a group for whom a topical option like capsaicin (or topical NSAIDs) makes particular practical sense, since topical application generally results in far lower systemic drug absorption than swallowing a pill, reducing (though not eliminating) some of those systemic risk considerations. That said, "lower systemic absorption" isn't "zero," and anyone with significant kidney or liver concerns should still confirm with a doctor before relying on any topical anti-inflammatory regularly.
Frequently asked questions
How long does the burning from capsaicin cream last?
It's typically most intense in the first several applications and tends to fade over one to two weeks of consistent daily use, based on patterns reported across the trials in this area.
Can I use capsaicin cream alongside a topical NSAID?
This hasn't been specifically tested in trials; ask a pharmacist or doctor before combining topical products on the same joint.
Is capsaicin cream better than oral joint supplements?
It works through a completely different, faster-acting local mechanism than oral supplements like glucosamine or collagen, which affect the joint systemically over weeks. See our supplements vs. NSAIDs comparison for how oral options are generally positioned.
What if the burning doesn't go away?
If burning is severe, doesn't improve after a week or two, or the skin becomes blistered or broken, stop use and consult a doctor or pharmacist.
FROM NUVIROX
Why we formulated Joint+ Restore
Joint+ Restore was built around ingredients studied for joint comfort and cartilage support, at doses in the range used in published research. We're not going to pretend a capsule replaces the fundamentals covered in this article — movement, weight management, and honest expectations about timelines — but for people looking for a research-informed supplement to add to that foundation, we designed Joint+ Restore to be exactly that. It's backed by a 60-day money-back guarantee, long enough to actually evaluate it the way the research in this article suggests you should.
Learn more about Joint+ Restore →The bottom line: topical capsaicin has solid meta-analytic support for reducing osteoarthritis pain, performing in the same general range as topical NSAIDs at licensed doses — the tradeoff is a burning sensation that fades with consistent use but drives a fair amount of early dropout. It's a reasonable option for pain concentrated in one or two accessible joints.
References
- Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta-analysis. Pharmacol Res Perspect. 2024. PMID: 38761115.
- Persson MSM, Stocks J, Walsh DA, Doherty M, Zhang W. The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthritis Cartilage. 2018 Dec;26(12):1575-1582. PMCID: PMC6267943.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.